- Conditions: Acute Myeloid Leukemia; Acute Leukemia; Chronic Myelogenous Leukemia; Malignant Lymphoma; Hodgkin's Disease; Multiple Myeloma; Lymphocytic Leukemia; Myeloproliferative Disorder; Polycythemia Vera; Myelofibrosis; Aplastic Anemia
Interventions: Drug: fludarabine/busulfan; Drug: fludarabine/ melphalan
Sponsors: University of Illinois; University of Illinois
Recruiting - verified September 2011 - Condition: Hyperbilirubinemia, Neonatal
Intervention: Dietary Supplement: Nutramigen Infant Formula
Sponsors: University of California, San Francisco; University of California, San Francisco
Not yet recruiting - verified March 2012 - Condition: HIV Positive Patient Receive Implant Supported Restoration
Intervention:
Sponsors: University of Alabama at Birmingham; University of Alabama at Birmingham; Astra Tech AB
Recruiting - verified February 2012 - Condition: Cholestasis
Intervention: Drug: Omegaven
Sponsors: Children's Hospital Medical Center, Cincinnati; Children's Hospital Medical Center, Cincinnati
Recruiting - verified April 2012 - Condition: Parenteral Nutrition Associated Liver Disease
Intervention: Drug: Lovaza (fish oil)
Sponsors: University of Tennessee; University of Tennessee
Recruiting - verified June 2011 - Condition: Liver Injury
Interventions: Drug: Omegaven™; Other: Historical Controls
Sponsors: Children's Hospital Los Angeles; Children's Hospital Los Angeles
Recruiting - verified July 2011 - Conditions: Cholestasis; Parenteral Nutrition
Intervention: Drug: Omegaven
Sponsors: Baylor College of Medicine; Baylor College of Medicine; Children's Hospital Boston
Recruiting - verified November 2011
 |
Bilirubin Clinical Trials |
